Professor Tomáš Hanke speaks to Scientia about innovative methods in vaccine design and development to combat HIV.
Prof Hanke, EAVI2020 PI at the University of Oxford spoke to Scientia which included his work on T cell response to second-generation conserved immunogen, HIVconsvX, and its predecessor, HIVconsv. Scientia is a popularised outreach journal that provides researchers with a platform to communicate their findings to others outside their speciality. Technical nomenclature is often transcribed into easier formats allowing further reach of the scientific outputs for maximising social impact, and engaging stakeholders.
Read the full article at the Scientia website.
Professor Tomáš Hanke – Use of Experimental Medicine for Rational Development of an Effective HIV Vaccine